The management of bile duct stones.
Bile duct stones are almost always associated with gallbladder stones and coexist with gallbladder stones in approximately 10% of patients. The frequency of coexisting bile duct stones increases with advancing age. In patients with stones in both the gallbladder and bile duct, therapeutic options for the latter include laparoscopic or open exploration of the bile duct, and pre-operative and post-operative endoscopic sphincterotomy and stone extraction. Endoscopic sphincterotomy remains the treatment of choice for bile duct stones after cholecystectomy. However, management algorithms in individual institutions will be influenced by surgical and endoscopic expertise and by other factors such as overall costs. After surgical or endoscopic removal of bile duct stones, estimates of the lifetime risk of recurrent stones range from 5%-20%. Increased life expectancy and the apparent absence of simple preventative measures indicate that the burden of bile duct stones on health expenditure is likely to increase in many countries.
Roberts-Thomson
Ian C
IC
Department of Gastroenterology and Hepatology, The Queen Elizabeth Hospital, Adelaide, Australia. ian.roberts-thomson@nwahs.sa.gov.au
D001649:Bile Duct Diseases / Q000175:diagnosis* / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D002763:Cholecystectomy / Q000009:adverse effects; D041761:Cholecystolithiasis / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D002769:Cholelithiasis / Q000175:diagnosis* / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D012008:Recurrence